Suggest an update

YC S21 · Active

Sensible Biotechnologies

Unlocking the next generation of mRNA medicines

Class
Summer 2021
Status
Active
Industry
Healthcare
Location
Oxford, England, United Kingdom
Team size
55

Website

https://sensible.bio

About

The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.